Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS Document date: 2018_12_19
ID: r79h9yzz_558
Snippet: Angiogenesis is essential for tumor progression, and microvessel density is known as a prognostic factor for many solid tumors. Recently, antiâ€angiogenic therapy has been a potential therapeutic strategy for various types of tumor. Histological assessment has only been reported for evaluating the angiogenesis in current veterinary medicine. For this reason, evaluating the angiogenesis is difficult in patients without surgery. Therefore, a novel.....
Document: Angiogenesis is essential for tumor progression, and microvessel density is known as a prognostic factor for many solid tumors. Recently, antiâ€angiogenic therapy has been a potential therapeutic strategy for various types of tumor. Histological assessment has only been reported for evaluating the angiogenesis in current veterinary medicine. For this reason, evaluating the angiogenesis is difficult in patients without surgery. Therefore, a novel evaluation method is needed. The aim of this study was to assess whether histological measurements of blood vessels is associated with mRNA levels of endothelial markers such as vWF and endoglin in spontaneous canine tumors. Additionally, we investigated the relationships between endothelial markers and angiogenic factors such as vascular endothelial growth factor (VEGF) and VEGF receptor2 (VEGFR2).
Search related documents:
Co phrase search for related documents- solid tumor and therapeutic strategy: 1, 2, 3
- solid tumor and tumor progression: 1, 2, 3, 4, 5
- solid tumor and tumor type: 1, 2, 3, 4, 5, 6, 7, 8, 9
- solid tumor and vascular VEGF endothelial growth factor: 1
- solid tumor and VEGF endothelial growth factor: 1
- solid tumor and veterinary medicine: 1
- study aim and therapeutic strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- study aim and tumor progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- study aim and tumor type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- study aim and vascular VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- study aim and VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- study aim and veterinary medicine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- therapeutic strategy and tumor progression: 1, 2, 3, 4, 5
- therapeutic strategy and tumor type: 1
- therapeutic strategy and vascular VEGF endothelial growth factor: 1
- therapeutic strategy and VEGF endothelial growth factor: 1
- tumor progression and vascular VEGF endothelial growth factor: 1, 2, 3
- tumor progression and VEGF endothelial growth factor: 1, 2, 3
- vascular VEGF endothelial growth factor and VEGF endothelial growth factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
Co phrase search for related documents, hyperlinks ordered by date